Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan To Support Trials Of 50 Drugs For Critical Diseases

This article was originally published in PharmAsia News

Executive Summary

Japan's health ministry says it will provide more than $791 million in support for clinical trials by the nation's drug makers to test 50 selected treatments for incurable and critical ailments. The Ministry of Health, Labor and Welfare said it invites various institutions, organizations and patient groups to recommend the treatments to be covered over a three-year period. The ministry said it also would expedite approvals for such drugs by cutting in half the process for reviewing them, now a one-year process. The drugs to be covered would be limited to those already approved in France, Germany, the United Kingdom and the United States. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel